Minerva Neurosciences Inc. | Ownership
Companies that own Minerva Neurosciences Inc.
Federated Global Investment Management Corp.
7,535,287
19.43%
0
0.56%
06/30/2018
Fidelity Management & Research Co.
4,568,394
11.78%
0
0.01%
06/30/2018
BlackRock Fund Advisors
2,023,089
5.22%
180,401
0%
06/30/2018
Highland Capital Management Fund Advisors LP
1,649,003
4.25%
-537,083
1.67%
06/30/2018
T. Rowe Price Associates, Inc.
1,528,989
3.94%
-140,974
0%
06/30/2018
The Vanguard Group, Inc.
1,462,821
3.77%
105,816
0%
06/30/2018
Franklin Advisers, Inc.
1,300,818
3.36%
65,818
0.01%
06/30/2018
Millennium Management LLC
919,471
2.37%
25,092
0.01%
06/30/2018
Sphera Funds Management Ltd.
820,120
2.12%
45,120
1.23%
06/30/2018
Cormorant Asset Management LP
607,903
1.57%
0
0.45%
06/30/2018
| Address |
1601 Trapelo Road
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.minervaneurosciences.com |
| Updated |
07/08/2019 |
| Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA. |
